Clopidogrel resistance and its effect on clinical outcomes in acute coronary syndrome.

Autor:	Lodhi H; Department of Cardiology, Army Hospital Research and Referral, Delhi Cantonment, New Delhi, 110010, India. Electronic address: heemanshulodhi@gmail.com., Bhat KG; Department of Cardiology, Army Hospital Research and Referral, Delhi Cantonment, New Delhi, 110010, India., Guleria VS; Department of Cardiology, Army Hospital Research and Referral, Delhi Cantonment, New Delhi, 110010, India., Pillai RKJ; Department of Cardiology, Army Hospital Research and Referral, Delhi Cantonment, New Delhi, 110010, India., Goel R; Department of Cardiology, Army Hospital Research and Referral, Delhi Cantonment, New Delhi, 110010, India., Sharma N; Department of Cardiology, Army Hospital Research and Referral, Delhi Cantonment, New Delhi, 110010, India., Sharma A; NMC Genetics India Private Limited, Gurugram, Haryana, 122001, India., Sharma V; NMC Genetics India Private Limited, Gurugram, Haryana, 122001, India.
Jazyk:	angličtina
Zdroj:	Indian heart journal [Indian Heart J] 2024 Jul-Aug; Vol. 76 (4), pp. 268-270. Date of Electronic Publication: 2024 Jul 14.
DOI:	10.1016/j.ihj.2024.07.003
Abstrakt:	Aim: The genetic polymorphism of CYP2C19 influences clopidogrel metabolism and resistance. Aim was to assess the association between CYP2C19 loss of function variation, clopidogrel resistance based on platelet reactivity units and clinical outcomes. Methods: A total of 668 patients of Acute Coronary Sundrome (ACS) who underwent Percutaneous Coronary Intervention (PCI) were subjected to genetic screening and 143 patients undrewent platelet function test to study the association between drug metabolization and its effects based on platelet reactivity unit values. Results: Clopidogrel resistance with CYP2C 19 loss of function variation was noted in 54.64% of patients. Clinical outcomes, such as target vessel revascularization, target lesion revascularization, in-stent restenosis, and stent thrombosis, were also studied. Conclusion: CYP2C19 loss of function variation is strongly associated with clopidogrel resistance and adverse clinical outcomes. Competing Interests: Declaration of competing interest All authors declare no competing interest. Dr. Anuka Sharma and Dr. Varun Sharma are the employees of NMC Genetics India Private Limited. (Copyright © 2024. Published by Elsevier, a division of RELX India, Pvt. Ltd.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu